Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 135th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
IRD	OPUS GENETICS INC	$207.58M	-774.20%	-170.70%	-968.51%	467.50%	5.05	1.24	100.00%	-466.10%	-465.63%
TNYA	TENAYA THERAPEUTICS INC	$135.04M	-95.50%	-76.80%	-102.71%	-122.30%	0.27	4.64	N/A	N/A	N/A
SNDX	SYNDAX PHARMACEUTICALS INC	$1.83B	-160.60%	-49.60%	-64.57%	-38.50%	3.78	4.64	95.40%	-279.30%	-253.32%
MLYS	MINERALYS THERAPEUTICS INC	$2.36B	-48.20%	-45.80%	-29.73%	-83.20%	0.04	25.50	N/A	N/A	N/A
EQ	EQUILLIUM INC	$92.56M	-148.80%	-109.40%	-76.58%	1,073.10%	0.12	10.85	100.00%	-555.90%	-547.72%
BNTC	BENITEC BIOPHARMA INC	$410.41M	-45.90%	-44.00%	-41.64%	2,647.30%	0.03	46.95	N/A	N/A	N/A
LENZ	LENZ THERAPEUTICS INC	$444.94M	-29.60%	-27.90%	-30.03%	-33.60%	0.09	12.69	100.00%	-336.50%	-333.61%
ICU	SEASTAR MEDICAL HOLDING CORP	$8.94M	-414.50%	-151.10%	-121.21%	425.70%	0.36	3.66	95.30%	-1,551.10%	-1,577.19%
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$215.75M	-55.20%	-49.90%	-42.88%	-210.80%	0.09	9.89	34.30%	-963.40%	-963.38%
MRNA	MODERNA INC	$16.02B	-31.40%	-24.40%	-30.16%	-30.90%	0.30	3.93	48.30%	-139.60%	-141.26%
ALLO	ALLOGENE THERAPEUTICS INC	$379.79M	-57.80%	-43.10%	-51.66%	-53.00%	0.40	8.19	N/A	N/A	N/A
KYMR	KYMERA THERAPEUTICS INC	$5.73B	-33.40%	-28.60%	-28.61%	-33.60%	0.17	7.38	100.00%	-674.80%	-674.04%
MGX	METAGENOMI INC	$57.82M	-43.20%	-31.10%	-41.23%	-34.60%	0.39	6.42	100.00%	-287.10%	-291.26%
SYRE	SPYRE THERAPEUTICS INC	$2.73B	-31.20%	-26.80%	-32.51%	-35.40%	0.11	10.91	N/A	N/A	N/A
MPLT	MAPLIGHT THERAPEUTICS INC	$770.43M	N/A	N/A	N/A	N/A	-0.09	13.22	N/A	N/A	N/A
PLRX	PLIANT THERAPEUTICS INC	$70.05M	-71.50%	-53.30%	-66.51%	-62.10%	0.38	13.94	N/A	N/A	N/A
LNAI	LUNAI BIOWORKS INC	$15.51M	-385.10%	-214.50%	1,021.63%	738.00%	-1.53	0.04	N/A	N/A	N/A
OCUL	OCULAR THERAPEUTIX INC	$1.99B	-71.70%	-51.20%	-33.56%	-272.30%	0.24	15.39	87.30%	-511.90%	-489.12%
EDIT	EDITAS MEDICINE INC	$177.67M	-348.50%	-78.60%	-143.62%	-160.90%	14.00	2.86	100.00%	-430.80%	-433.42%
VNDA	VANDA PHARMACEUTICALS INC	$447.36M	-16.80%	-13.40%	-22.17%	-33.30%	0.29	3.12	94.40%	-39.70%	-50.52%
COEP	COEPTIS THERAPEUTICS HOLDINGS INC	$60.18M	-172.70%	-92.60%	-95.84%	-192.70%	0.32	2.21	73.00%	-2,251.50%	-2,195.46%
PROK	PROKIDNEY CORP	$562.56M	N/A	-18.10%	-20.87%	-24.90%	-0.03	10.32	100.00%	-9,547.40%	-9,049.33%
SVRA	SAVARA INC	$1.08B	-86.60%	-65.40%	-93.14%	-66.40%	0.49	7.65	N/A	N/A	N/A
VYNE	VYNE THERAPEUTICS INC	$18.50M	-80.60%	-66.00%	-104.91%	-173.00%	0.13	8.87	100.00%	-6,425.20%	-6,424.43%
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	$16.83M	-219.00%	-178.10%	-82.92%	-1,205.80%	0.11	10.42	N/A	N/A	N/A
IMNM	IMMUNOME INC	$2.28B	-87.20%	-75.60%	-83.13%	-373.20%	0.13	8.90	100.00%	-2,301.30%	-2,301.30%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$323.64M	-67.40%	-65.30%	-33.21%	20,901.30%	0.04	23.98	N/A	N/A	N/A
LTRN	LANTERN PHARMA INC	$29.53M	-126.00%	-97.40%	-197.36%	-232.80%	0.42	3.33	N/A	N/A	N/A
PHVS	PHARVARIS NV	$1.72B	-66.20%	-60.20%	N/A	-1,563.70%	0.09	N/A	N/A	N/A	N/A
LITS	LITE STRATEGY INC	$38.99M	-27.10%	-26.20%	-10.31%	-47.00%	0.01	12.39	N/A	N/A	N/A
APLM	APOLLOMICS INC	$21.24M	-380.10%	-136.50%	-4,767.85%	1,243.90%	-3.53	0.97	100.00%	-366.90%	-362.92%
SAVA	CASSAVA SCIENCES INC	$98.07M	-95.80%	-75.30%	-129.80%	2,002.20%	0.59	2.27	N/A	N/A	N/A
BDRX	BIODEXA PHARMACEUTICALS PLC	$0.00	-244.80%	-171.40%	-217.16%	-1,804.70%	0.30	3.63	100.00%	-3,171.60%	-3,445.89%
ALXO	ALX ONCOLOGY HOLDINGS INC	$111.15M	-138.90%	-96.70%	-193.39%	-132.10%	0.85	2.40	N/A	N/A	N/A
NRXP	NRX PHARMACEUTICALS INC	$53.67M	N/A	-489.90%	148.69%	172.10%	-1.58	0.29	59.90%	-15,727.70%	-15,727.69%
KTTA	PASITHEA THERAPEUTICS CORP	$5.40M	-97.90%	-88.00%	-110.13%	5,105.70%	0.12	4.02	N/A	N/A	N/A
IMMX	IMMIX BIOPHARMA INC	$226.31M	-263.50%	-120.00%	-254.88%	547.00%	1.43	1.53	N/A	N/A	N/A
TVRD	TVARDI THERAPEUTICS INC	$34.90M	-115.90%	-33.70%	-31.65%	-30.90%	0.40	3.48	100.00%	-346.50%	-220.05%
KYTX	KYVERNA THERAPEUTICS INC	$347.30M	-77.90%	-65.80%	-104.98%	-103.60%	0.23	5.16	N/A	N/A	N/A
ARVN	ARVINAS INC	$865.74M	-9.80%	-6.10%	-8.39%	-8.60%	0.50	5.70	100.00%	-18.70%	-18.80%
MCRB	SERES THERAPEUTICS INC	$126.29M	15.30%	3.60%	4.46%	3.60%	2.28	2.30	100.00%	1,536.80%	1,536.75%
ATRA	ATARA BIOTHERAPEUTICS INC	$35.19M	-41.80%	39.30%	225.66%	52.50%	-1.82	1.02	81.60%	15.40%	17.99%
GLPG	GALAPAGOS NV	$2.20B	-16.20%	-11.30%	-14.48%	-14.00%	0.44	8.63	71.10%	-151.40%	-158.11%
ENLV	ENLIVEX THERAPEUTICS LTD	$28.18M	-62.90%	-53.30%	-82.65%	-29,748.70%	0.20	6.43	N/A	N/A	N/A
CRNX	CRINETICS PHARMACEUTICALS INC	$4.30B	-35.10%	-32.00%	-37.71%	-36.00%	0.12	15.12	100.00%	-27,563.30%	-27,563.32%
KURA	KURA ONCOLOGY INC	$681.35M	-65.40%	-30.60%	-40.35%	-41.40%	1.68	5.12	100.00%	-208.50%	-204.82%
ELTX	ELICIO THERAPEUTICS INC	$145.51M	-5,657.90%	-160.70%	-205.92%	-320.10%	6.41	3.30	N/A	N/A	N/A
ANIX	ANIXA BIOSCIENCES INC	$98.80M	-66.60%	-62.80%	-77.43%	-76.90%	0.14	8.08	N/A	N/A	N/A
TELO	TELOMIR PHARMACEUTICALS INC	$39.54M	-566.60%	-447.90%	-161.29%	2,487.30%	0.06	17.51	N/A	N/A	N/A
CNTX	CONTEXT THERAPEUTICS INC	$209.48M	-30.90%	-29.60%	-36.12%	8,256.50%	0.08	13.10	N/A	N/A	N/A
EWTX	EDGEWISE THERAPEUTICS INC	$3.08B	-30.90%	-29.40%	-27.99%	-33.30%	0.04	26.51	N/A	N/A	N/A
SANA	SANA BIOTECHNOLOGY INC	$1.05B	-120.60%	-53.80%	-58.61%	-127.50%	1.23	4.56	N/A	N/A	N/A
NRXS	NEURAXIS INC	$46.34M	-377.70%	-162.10%	-284.96%	703.70%	1.53	1.59	84.30%	-249.00%	-222.82%
LPCN	LIPOCINE INC	$47.14M	-30.60%	-28.20%	-38.71%	-42.10%	0.14	8.25	100.00%	-126.70%	-126.66%
MAZE	MAZE THERAPEUTICS INC	$2.17B	-65.20%	-31.20%	-31.61%	-208.60%	0.11	17.70	N/A	N/A	N/A
APVO	APTEVO THERAPEUTICS INC	$6.27M	-411.10%	-168.00%	-123.81%	-519.70%	0.55	4.03	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$1.17B	-73.50%	-57.60%	-70.35%	-174.50%	0.64	5.66	100.00%	-1,266.00%	-1,264.37%
IMVT	IMMUNOVANT INC	$5.51B	-65.80%	-60.40%	-46.70%	25,054.10%	0.07	15.74	N/A	N/A	N/A
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$215.08M	-28.70%	-21.10%	-32.68%	-220.10%	0.26	7.86	100.00%	-68.30%	-83.92%
TAOX	TAO SYNERGIES INC	$28.23M	-244.20%	-152.10%	-153.61%	-540.70%	0.11	17.61	100.00%	-13,058.70%	-12,829.93%
COGT	COGENT BIOSCIENCES INC	$5.28B	-126.20%	-89.70%	-80.45%	-153.00%	0.41	6.38	N/A	N/A	N/A
FULC	FULCRUM THERAPEUTICS INC	$527.11M	-32.20%	-30.00%	-34.99%	-38.20%	0.08	17.70	N/A	N/A	N/A
ACIU	AC IMMUNE SA	$316.81M	-83.50%	-35.80%	-97.78%	-248.70%	1.75	1.16	100.00%	-1,643.90%	-1,639.75%
GPCR	STRUCTURE THERAPEUTICS INC	$4.54B	-26.10%	-24.70%	-27.14%	-31.10%	0.08	14.15	N/A	N/A	N/A
IPSC	CENTURY THERAPEUTICS INC	$148.42M	-13.40%	-8.80%	-11.09%	-11.90%	0.39	6.25	100.00%	-23.40%	-21.79%
CLYM	CLIMB BIO INC	$370.92M	-26.40%	-25.60%	-28.62%	-33.40%	0.03	18.38	N/A	N/A	N/A
RCUS	ARCUS BIOSCIENCES INC	$2.27B	-68.20%	-31.30%	-44.93%	-44.90%	1.23	3.65	100.00%	-142.10%	-138.33%
ABOS	ACUMEN PHARMACEUTICALS INC	$145.38M	-97.40%	-70.40%	-107.41%	-81.60%	0.53	6.02	N/A	N/A	N/A
MIST	MILESTONE PHARMACEUTICALS INC	$149.90M	-2,372.70%	-85.10%	-70.24%	-73.30%	3.28	8.24	N/A	N/A	N/A
NGNE	NEUROGENE INC	$266.89M	-29.80%	-27.50%	-31.17%	-38.50%	0.08	18.39	N/A	N/A	N/A
RNXT	RENOVORX INC	$36.28M	-122.20%	-90.70%	-123.25%	3,053.60%	0.39	5.83	67.80%	-1,196.70%	-1,238.04%
BCYC	BICYCLE THERAPEUTICS PLC	$392.62M	-35.50%	-29.20%	-36.37%	-763.20%	0.24	10.66	100.00%	-884.50%	-891.54%
PALI	PALISADE BIO INC	$244.37M	-240.70%	-137.30%	-320.89%	577.10%	1.17	1.96	N/A	N/A	N/A
BEAM	BEAM THERAPEUTICS INC	$2.69B	-42.90%	-31.50%	-36.74%	-43.30%	0.36	6.02	100.00%	-744.40%	-744.41%
IMTX	IMMATICS NV	$1.17B	-23.30%	-19.10%	-26.21%	-40.90%	0.24	7.36	100.00%	-136.70%	-141.11%
CMPX	COMPASS THERAPEUTICS INC	$1.16B	-48.90%	-42.50%	-30.07%	-58.90%	0.10	17.82	N/A	N/A	N/A
KLRS	KALARIS THERAPEUTICS INC	$155.98M	-76.00%	-52.30%	-66.92%	-1,029.20%	0.94	12.89	N/A	N/A	N/A
PGEN	PRECIGEN INC	$1.52B	-5,766.20%	-311.30%	-176.76%	-238.60%	3.09	4.04	30.30%	-6,750.10%	-3,899.94%
WVE	WAVE LIFE SCIENCES LTD	$2.25B	-75.60%	-43.00%	-78.43%	504.40%	0.88	2.51	100.00%	-111.60%	-111.64%
NVAX	NOVAVAX INC	$1.34B	-167.00%	25.50%	50.00%	71.10%	-8.53	2.27	91.80%	32.10%	35.22%
DRMA	DERMATA THERAPEUTICS INC	$1.88M	-192.00%	-140.20%	N/A	-2,889.20%	0.28	N/A	N/A	N/A	N/A
LCTX	LINEAGE CELL THERAPEUTICS INC	$391.56M	-118.80%	-66.80%	-84.30%	3,452.30%	3.12	4.50	97.80%	-625.50%	-625.53%
ALEC	ALECTOR INC	$213.94M	-123.00%	-27.50%	-42.18%	-38.10%	4.81	3.76	100.00%	-156.00%	-155.96%
IMMP	IMMUTEP LTD	$382.62M	-36.90%	-34.30%	-42.57%	-130.80%	0.09	11.69	100.00%	-594.60%	-594.28%
MTVA	METAVIA INC	$4.01M	-229.50%	-105.30%	-256.14%	214.30%	1.33	1.74	N/A	N/A	N/A
BLTE	BELITE BIO INC	$5.98B	N/A	N/A	N/A	N/A	0.03	34.37	N/A	N/A	N/A
NERV	MINERVA NEUROSCIENCES INC	$33.57M	N/A	-43.70%	-55.18%	-24.10%	-1.81	4.87	N/A	N/A	N/A
ACRV	ACRIVON THERAPEUTICS INC	$52.70M	-53.70%	-48.30%	-62.69%	-69.00%	0.13	8.75	N/A	N/A	N/A
PDSB	PDS BIOTECHNOLOGY CORP	$35.02M	-209.00%	-83.30%	-150.77%	-287.10%	2.67	2.09	N/A	N/A	N/A
CAPR	CAPRICOR THERAPEUTICS INC	$1.13B	-71.00%	-56.10%	-83.42%	-78.10%	0.51	3.59	100.00%	-736.60%	-736.62%
ABCL	ABCELLERA BIOLOGICS INC	$945.90M	-17.00%	-12.60%	-15.92%	-17.70%	0.41	10.10	100.00%	-486.00%	-580.13%
CADL	CANDEL THERAPEUTICS INC	$320.06M	-29.20%	-22.60%	-26.21%	353.60%	0.17	8.25	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$98.92M	-50.00%	-44.00%	-57.49%	-52.80%	0.15	11.65	N/A	N/A	N/A
CTMX	CYTOMX THERAPEUTICS INC	$960.70M	44.50%	20.30%	24.11%	60.40%	0.47	3.64	100.00%	24.70%	24.87%
QCLS	Q/C TECHNOLOGIES INC	$16.42M	-121.40%	-48.90%	-25.40%	-419.50%	1.11	1.71	N/A	N/A	N/A
CRSP	CRISPR THERAPEUTICS AG	$4.64B	-26.40%	-22.50%	-22.79%	-24.00%	0.17	16.22	100.00%	-1,273.70%	-1,263.99%
CGEM	CULLINAN THERAPEUTICS INC	$722.50M	-42.10%	-39.80%	-48.01%	-49.30%	0.07	10.45	N/A	N/A	N/A
RGNX	REGENXBIO INC	$522.94M	-78.30%	-34.50%	-33.89%	-26.00%	2.25	2.67	87.20%	-110.30%	-84.16%
CTNM	CONTINEUM THERAPEUTICS INC	$437.74M	-32.30%	-30.30%	-32.19%	-35.60%	0.06	29.07	N/A	N/A	N/A
MNPR	MONOPAR THERAPEUTICS	$385.92M	-25.70%	-24.80%	-13.73%	-155.60%	0.02	56.10	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Feb 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

Biocryst Pharmaceuticals (NASDAQ:BCRX) is the #1 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Biocryst Pharmaceuticals (NASDAQ:BCRX) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: B.

Biocryst Pharmaceuticals (NASDAQ:BCRX) has a Due Diligence Score of 15, which is -9 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates BCRX as a "A".

BCRX passed 5 out of 33 due diligence checks and has weak fundamentals. Biocryst Pharmaceuticals has seen its stock lose -26.92% over the past year, overperforming other biotech stocks by 4 percentage points.

Biocryst Pharmaceuticals has an average 1 year price target of $21.86, an upside of 242.59% from Biocryst Pharmaceuticals's current stock price of $6.38.

Biocryst Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Biocryst Pharmaceuticals, 28.57% have issued a Strong Buy rating, 57.14% have issued a Buy, 14.29% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #2 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: B.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 16, which is -8 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates JAZZ as a "A".

JAZZ passed 5 out of 33 due diligence checks and has weak fundamentals. Jazz Pharmaceuticals has seen its stock return 37.84% over the past year, overperforming other biotech stocks by 69 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $213.27, an upside of 28.87% from Jazz Pharmaceuticals's current stock price of $165.50.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 63.64% have issued a Strong Buy rating, 27.27% have issued a Buy, 9.09% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #3 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: A, Sentiment: B, Safety: C, Financials: C, and AI: B.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 33, which is 9 points higher than the biotech industry average of 24.

PHAR passed 10 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 81.4% over the past year, overperforming other biotech stocks by 112 percentage points.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 26.41%, which is 21 percentage points higher than the biotech industry average of 5.56%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.33%, which is 2 percentage points higher than the biotech industry average of 5.56%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.97%, which is -4 percentage points lower than the biotech industry average of 5.56%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 49.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.73% in the last day, and down -0.36% over the last week. Roivant Sciences was the among the top gainers in the biotechnology industry, gaining 22.14% yesterday.

Roivant Sciences shares are trading higher after the company reported better-than-expected Q3 sales results.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the biotech industry average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -3.89% in the past year. It has overperformed other stocks in the biotech industry by 27 percentage points.

2. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 57, which is 41 points higher than the biotech industry average of 16. It passed 4 out of 7 valuation due diligence checks.

Innoviva's stock has gained 19.39% in the past year. It has overperformed other stocks in the biotech industry by 50 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 57, which is 41 points higher than the biotech industry average of 16. It passed 4 out of 7 valuation due diligence checks.

Incyte's stock has gained 44.62% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

64.15% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 67.9% over the next year.

3.35% of biotech stocks have a Zen Rating of A (Strong Buy), 6.5% of biotech stocks are rated B (Buy), 41.93% are rated C (Hold), 37.53% are rated D (Sell), and 10.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 234.95x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.